Status: Recruiting
A Pilot Study on Efficacy of Digital Therapeutic NDTx-02 for Executive Function in Children and Adolescents With ADHD or ASD
The purpose of this study is to explore the preliminary safety and effectiveness of the digital therapeutic device 'NDTx-02' in supporting improvements of executive function in children and adolescents diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) or Autism Spectrum Disorder (ASD).
Participants needed: 48
Trial details
Age: 5-12Biological sex: AllType: InterventionalSponsor: Neudive Inc.Updated: Nov 21, 2025Locations: 3
Eligibility criteria
Children and adolescents aged 5 to 12 years at the time of screening [+7]
A risk of clinically significant behavioral problems, emotion regulation problem... [+8]